Hematoporphyrin derivative uptake and photodynamic therapy in pancreatic carcinoma.
Little information is currently available concerning the uptake of porphyrins by pancreatic tumors, or the effect of photodynamic therapy (PDT) on pancreatic cancer. In Syrian golden hamsters (n = 33), the organ distribution of 125I-labeled dihematoporphyrin ether (DHE) was studied in a pancreatic cancer model. In the same animal model the effect of PDT was studied using a gold vapor laser for energy delivery 3 hr after the injection of DHE (n = 7). DHE was 2.4 times more concentrated in the pancreatic tumor than in the nontumorous pancreas at 3 hr. Simultaneously there was a considerable accumulation of DHE in the surrounding gastrointestinal tract, causing perforation of the duodenum and jejunum with resultant death in four (57%) animals after PDT. Photodynamic therapy caused extensive tumor necrosis without any obvious effect on the nontumor-bearing pancreas. Damage to the surrounding tissue in the hamster indicates that precautions should be taken if PDT is to be used clinically in pancreatic cancer. Intratumoral injection of DHE may give higher drug concentrations with greater specificity for tumor treatment.
Schroder
T
T
Department of Surgery, University of Cincinnati Medical Center, Ohio.
Chen
I W
IW
Sperling
M
M
Bell
R H
RH
Brackett
K
K
Joffe
S N
SN
D000230:Adenocarcinoma / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D000818:Animals; D006224:Cricetinae; D004353:Drug Evaluation, Preclinical; D017324:Hematoporphyrin Derivative; D006414:Hematoporphyrin Photoradiation; D006415:Hematoporphyrins / Q000493:pharmacokinetics* / Q000627:therapeutic use; D007457:Iodine Radioisotopes; D008647:Mesocricetus; D009602:Nitrosamines; D010179:Pancreas / Q000378:metabolism / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D010778:Photochemotherapy; D011838:Radiation-Sensitizing Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D013997:Time Factors; D014018:Tissue Distribution
D006415:Hematoporphyrins; D007457:Iodine Radioisotopes; D009602:Nitrosamines; D011838:Radiation-Sensitizing Agents; C013622:nitrosobis(2-oxopropyl)amine; D017324:Hematoporphyrin Derivative